<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Pantoprazole - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Pantoprazole</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">GI</div>
      <h1>Pantoprazole</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Pantoprazole 40mg Tablets</li>
          <li>Pantoprazole 40mg Injection</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <p><strong>GERD / reflux symptoms (short-term)</strong></p>
        <ul>
          <li>40 mg PO once daily</li>
        </ul>
        <p><strong>Erosive esophagitis / peptic ulcer disease (short-term)</strong></p>
        <ul>
          <li>40 mg PO once daily (typical)</li>
        </ul>
        <p><strong>Unable to take PO or severe symptoms (protocol-dependent)</strong></p>
        <ul>
          <li>40 mg IV once daily</li>
        </ul>
        <p><strong>Suspected upper GI bleed / high-risk ulcer disease (protocol-dependent)</strong></p>
        <ul>
          <li>IV dosing strategies vary; follow local protocol/medical direction</li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>GERD and acid-related symptoms</li>
          <li>Erosive esophagitis</li>
          <li>Peptic ulcer disease (selected cases)</li>
          <li>Acid suppression when PO not feasible (IV use; protocol-dependent)</li>
          <li>Part of selected upper GI bleed pathways (protocol-dependent)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypersensitivity to pantoprazole/PPIs</li>
          <li>Concomitant use with rilpivirine (avoid)</li>
          <li>Caution: long-term/high-dose use (if prolonged), history of hypomagnesemia, severe liver disease</li>
          <li>Interaction considerations: clopidogrel (clinical significance varies; use local guidance)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Headache, diarrhea, nausea, abdominal pain</li>
          <li>Long-term use (if prolonged): hypomagnesemia, B12 deficiency risk, fractures/infections (context-dependent)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <p><strong>PO tablets</strong></p>
        <ul>
          <li>Swallow whole; do not crush/chew if delayed-release formulation</li>
        </ul>
        <p><strong>IV injection</strong></p>
        <ul>
          <li>Reconstitute/dilute and administer per product monograph/local protocol</li>
          <li>Use appropriate IV compatibility and flush practices per local guidance</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Clinical response (pain, reflux symptoms, bleeding symptoms if relevant)</li>
          <li>If prolonged therapy or high-risk patient: magnesium and B12 when feasible; assess for diarrhea/infection risk</li>
          <li>If GI bleed suspected: hemodynamics and ongoing bleeding signs per broader pathway</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>If diagnostics are limited, treat symptomatically but reassess for red flags (GI bleed, persistent vomiting, severe abdominal pain)</li>
          <li>Document start date/indication to avoid unnecessary prolonged PPI use onboard</li>
          <li>If clopidogrel is being used for ACS pathways, apply local guidance regarding co-administration</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (pantoprazole): https://pdf.hres.ca/dpd_pm/00041256.PDF</li>
          <li>Health Canada product monograph (pantoprazole sodium; recent): https://pdf.hres.ca/dpd_pm/00076435.PDF</li>
          <li>BCEHS drug monograph (pantoprazole): https://handbook.bcehs.ca/drug-monographs/pantoprazole/</li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
